Individuals Coming Off Weight-Loss Medications Put On Pounds at a Quadrupled Rate Than Those on Conventional Diets

New research suggests that patients who stop using blockbuster GLP-1 drugs like Mounjaro or Wegovy can put back on shed pounds much more quickly than those who stop traditional diet and exercise plans.

Findings released in a major medical journal demonstrates that while overweight individuals can lose substantial amounts of their body weight while on the medication, the mass comes back at an average rate of 0.8 kg per month upon discontinuation.

"Individuals buying such medications should be cognizant of the potential of rapid weight regain when the treatment concludes," warns expert Dr. Susan Jebb.

This pace of recovery implies a return to pre-treatment mass within about 18 months.

Weighing Approaches

The study, which examined 37 of trials involving over 9,000 of patients, compared the outcomes of these new drugs with older methods.

The team point out that individuals who shed pounds through lifestyle changes alone generally see a less rapid weight regain—approximately 0.1 kg a month—post-intervention.

Explaining the Quick Regain

Doctors suggest the mechanism of the jabs accounts for the amplified regain.

The injections copy a body's own chemical called glucagon-like peptide-1, which controls feelings of fullness.

"Sustained high doses of GLP-1 concentrations far above than the body's typical production might result in the body to generate a reduced amount of its own natural hormone, and may also lessen responsiveness to its actions," explained Dr. Adam Collins, a dietetics specialist.

"Withdrawal of this GLP-1 'fix' results in hunger is no longer kept in check, making excessive eating much more probable."

An Ongoing Issue?

Medical guidelines recommend the injections for individuals with obesity-related health risks, alongside prescribed diet and exercise modifications.

Many experts argue that, due to the significant potential of weight regain, the therapy should be considered long-term.

This opinion is reinforced by pharmaceutical companies, who state that the findings "emphasize the chronic character of excess weight," comparing it to managing conditions like high blood pressure.

User Testimonies

Users who have discontinued the medication describe a powerful return of cravings.

"It was like a switch activating and you become ravenous," recalled one woman.

The struggle is compounded if individuals have not developed permanent dietary or behavioural changes during therapy.

Growing Interest

Figures suggest that millions of adults in the UK have tried these injections in the past year, with demand being substantial.

• Adoption is greater among females than men.
• The 40s and 50s demographic shows the greatest level of interest.
• Many access the drugs through private prescriptions rather than the NHS.

In conclusion, experts emphasize that while these medications are powerful agents for weight loss, they are not a standalone solution and lasting health benefits likely depends on ongoing behavioural changes.